ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
PowerUp Acquisition Corporation

PowerUp Acquisition Corporation (PWUP)

11.70
-0.24
( -2.01% )
Updated: 10:48:05

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
11.70
Bid
11.50
Ask
12.89
Volume
2,750
11.645 Day's Range 12.27
10.91 52 Week Range 14.47
Market Cap
Previous Close
11.94
Open
12.05
Last Trade
100
@
11.7
Last Trade Time
10:47:13
Financial Volume
US$ 32,500
VWAP
11.8181
Average Volume (3m)
865
Shares Outstanding
8,991,229
Dividend Yield
-
PE Ratio
23.56
Earnings Per Share (EPS)
0.5
Revenue
-
Net Profit
4.46M

About PowerUp Acquisition Corporation

PowerUp Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. PowerUp Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Headquarters
Grand Cayman, Cym
Founded
2023
PowerUp Acquisition Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PWUP. The last closing price for PowerUp Acquisition was US$11.94. Over the last year, PowerUp Acquisition shares have traded in a share price range of US$ 10.91 to US$ 14.47.

PowerUp Acquisition currently has 8,991,229 shares outstanding. The market capitalization of PowerUp Acquisition is US$107.36 million. PowerUp Acquisition has a price to earnings ratio (PE ratio) of 23.56.

PWUP Latest News

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

Highlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of approximately $316 million.Industry-Leading Platform: Aspire is focused on developing...

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

Humacao, PR and New York, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Aspire Biopharma, Inc. (“Aspire” or the “Company”), a developer of a multi-faceted patent protected disruptive drug delivery...

PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

New York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that, on June 3, 2024, the Company received a notice (the “Notice”) from...

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

New York, NY, May 20, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that its extraordinary general meeting of shareholders (the “Meeting”...

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

New York, NY, May 16, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that its extraordinary general meeting of shareholders (the “Meeting”...

PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination

Tarrytown, NY and New York, NY, Jan. 29, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (“PowerUp”) (Nasdaq: PWUP) and Visiox Pharmaceuticals, Inc. (“Visiox”), a commercial-stage...

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Tarrytown, NY and New York, NY, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Visiox Pharmaceuticals, Inc. (“Visiox” or the “Company”), a commercial-stage biopharmaceutical company, and PowerUp Acquisition...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.2452.1388040157111.4551311.455526011.92955266CS
40.21.7391304347811.51311.4204311.76884775CS
120.292.5416301489911.411311.486511.70531095CS
260.363.174603174611.3414.4711.21106311.71342178CS
520.797.2410632447310.9114.4710.91783911.31745121CS
1561.7171014.479.944387410.41570737CS
2601.7171014.479.944387410.41570737CS

PWUP - Frequently Asked Questions (FAQ)

What is the current PowerUp Acquisition share price?
The current share price of PowerUp Acquisition is US$ 11.70
How many PowerUp Acquisition shares are in issue?
PowerUp Acquisition has 8,991,229 shares in issue
What is the market cap of PowerUp Acquisition?
The market capitalisation of PowerUp Acquisition is USD 107.36M
What is the 1 year trading range for PowerUp Acquisition share price?
PowerUp Acquisition has traded in the range of US$ 10.91 to US$ 14.47 during the past year
What is the PE ratio of PowerUp Acquisition?
The price to earnings ratio of PowerUp Acquisition is 23.56
What is the reporting currency for PowerUp Acquisition?
PowerUp Acquisition reports financial results in USD
What is the latest annual profit for PowerUp Acquisition?
The latest annual profit of PowerUp Acquisition is USD 4.46M
What is the registered address of PowerUp Acquisition?
The registered address for PowerUp Acquisition is PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1-1104
Which industry sector does PowerUp Acquisition operate in?
PowerUp Acquisition operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RNAZTransCode Therapeutics Inc
US$ 14.76
(116.11%)
19.44M
SLXNSilexion Therapeutics Corporation
US$ 1.13
(94.83%)
179.06M
YIBOPlanet Image International Ltd
US$ 4.82
(56.49%)
49.8M
TRIBTrinity Biotech PLC
US$ 1.145
(50.66%)
100.12M
HEPAHepion Pharmaceuticals Inc
US$ 0.2247
(36.18%)
236.37M
LPTXLeap Therapeutics Inc
US$ 0.6491
(-71.15%)
8.26M
STSSSharps Technology Inc
US$ 0.4355
(-70.17%)
11.97M
SABSSAB Biotherapeutics Inc
US$ 2.24
(-48.62%)
948.03k
MGOLMGO Global Inc
US$ 0.1671
(-40.95%)
15.82M
INKTMiNK Therapeutics Inc
US$ 5.72
(-35.29%)
69.36k
NVDANVIDIA Corporation
US$ 122.5199
(3.46%)
259.82M
HEPAHepion Pharmaceuticals Inc
US$ 0.2247
(36.18%)
236.37M
SLXNSilexion Therapeutics Corporation
US$ 1.13
(94.83%)
179.06M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.4993
(21.16%)
146.23M
TRIBTrinity Biotech PLC
US$ 1.15
(51.32%)
100.12M

PWUP Discussion

View Posts
barnyarddog barnyarddog 1 week ago
PowerUp will hold an extraordinary general meeting..... to consider matters relating to the Business Combination at 9:00 AM, Eastern Time, on February 4, 2025.

Proposal No. 1 — The Business Combination Proposal —

PowerUp has unanimously approved the Business Combination Agreement and the transactions contemplated thereby, including the Business Combination and PowerUp Domestication, and unanimously recommends that shareholders vote “FOR” the adoption of the Business Combination Agreement and approval of the transactions contemplated thereby, including the Business Combination and PowerUp Domestication, and “FOR” all other proposals presented to PowerUp’s shareholders in the proxy statement/prospectus.

424B3
01/14/2025
https://www.otcmarkets.com/filing/html?id=18106839&guid=3D0-kKRdcsFTh3h
👍️0
barnyarddog barnyarddog 1 month ago
oops
👍️0
barnyarddog barnyarddog 1 month ago
Aspire Pharma acquires Canute to expand strategic portfolio

7 October 2024
https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/latest-pharmaceutical-manufacturing-news/aspire-pharma-acquires-canute-to-expand%C2%A0strategic-portfolio/
👍️0
barnyarddog barnyarddog 1 month ago
About the Company

https://aspirebiolabs.com/about/

I dont know if this is the merging company...
👍️0
barnyarddog barnyarddog 1 month ago
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

September 03, 2024
https://www.globenewswire.com/news-release/2024/09/03/2939657/0/en/Aspire-Biopharma-Inc-and-PowerUp-Acquisition-Corp-Announce-Business-Combination-Agreement-to-Create-Nasdaq-listed-Biopharmaceutical-Company-Driving-Breakthrough-Innovations-in-FDA-.html

Aspire Overview

Aspire Biopharma, Inc. is a privately held, early-stage biopharmaceutical technology company founded in 2021. The Company is engaged in the business of developing and marketing a disruptive technology for novel delivery mechanisms for “do no harm” FDA approved drugs, nutraceuticals and supplements. Aspire has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, patient compliance and safety and rapid response and absorption time when required and desired.
👍️0

Your Recent History

Delayed Upgrade Clock